TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer
about
Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancerConsistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development.Expression of delta-catenin is associated with progression of human astrocytoma.δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and metabolic reprogramming.Amplified genes may be overexpressed, unchanged, or downregulated in cervical cancer cell lines.Genome-wide screening for genetic alterations in esophageal cancer by aCGH identifies 11q13 amplification oncogenes associated with nodal metastasisFrequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas.Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid.delta-Catenin promotes prostate cancer cell growth and progression by altering cell cycle and survival gene profilesTissue microarray studies in bladder cancer.Inhibition and termination of physiological responses by GTPase activating proteins.The many faces of the guanine-nucleotide exchange factor trio.Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho-GTPase pathway genes in NF1 tumorigenesis.Expression and biological role of δ-catenin in human ovarian cancer.Genetic alterations of δ-catenin/NPRAP/Neurojungin (CTNND2): functional implications in complex human diseases.Altered JS-2 expression in colorectal cancers and its clinical pathological relevance.Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.Genome profiling of pancreatic adenocarcinoma.Identification of a 7-gene signature that predicts relapse and survival for early stage patients with cervical carcinoma.Expression analysis of apolipoprotein E and its associated genes in gastric cancer.Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression.Scattered genomic amplification in dedifferentiated liposarcoma.Mammalian diseases of phosphatidylinositol transfer proteins and their homologs.Supervillin binds the Rac/Rho-GEF Trio and increases Trio-mediated Rac1 activation.Upregulated TRIO expression correlates with a malignant phenotype in human hepatocellular carcinoma.Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data
P2860
Q33274761-49AF7EB1-9B2C-4467-86F4-76EDCAEEB8E4Q33382065-363579C7-CE1F-4905-9EF5-9428A2ED2290Q33487902-F7BE9A8D-9997-4051-BB86-2EAF01BEA25BQ34029712-09276F03-692F-4F6C-A16B-FB59591B998CQ34040584-CDA4282A-21D8-4ABB-8770-755F3A461F53Q34193299-FA8E2A36-A8D2-49F3-B5BD-A411081EC541Q34326537-121F4378-8BC7-4429-BB09-41AB4B6F8F3CQ34534399-0ABAFC5B-C566-42EA-A76B-29E4584D0D68Q35000289-2F94847A-F0BC-46A9-9803-B8B689DD255BQ35633033-BC27E055-C5F7-4916-ACFD-AF953AF58013Q37139096-E20C02BC-C0FF-424F-926A-D3E3DCA0EE70Q37278995-FFDEB193-7944-4017-AB84-2E19B23C9871Q37980724-96F15EF5-E771-4984-98C4-81C24EBEA30AQ38053051-1F8A1F24-3400-4693-AD8E-39C5ED25E7CAQ38327730-9FA17F20-A870-43BE-96C6-F5998706A6BBQ38402842-9B54E9F3-F546-4F73-B220-2D7D799E6186Q38886738-9CBAE689-1568-4C52-9BAB-1853D21441A0Q39498261-15BFC174-D1E9-4393-9F79-2E6C7172AECDQ39540562-5AF01012-2847-4A26-8D70-A2F060C552E0Q39574924-5C63E746-3B45-4FF0-919F-CE22355F3810Q39660335-24127E74-5DCC-446C-8F9F-13B634758E6EQ40257748-7FEAEFAF-35D3-46B9-9F7D-818571B487CFQ40426945-30967811-83AD-41AF-940F-586BF2487465Q41051350-D64E130D-E0DA-40BC-8B1F-D12DB5DC0777Q42736093-49AD67B9-EB3F-4793-AE69-AB7DB27F194EQ43187995-00C4643C-2C78-4A69-8790-4BEFB64AE80FQ53551635-D85679E9-1E17-4D76-8DC3-6D9AB513BF6AQ58122640-C208D0E2-E6B3-48D9-863E-859E572323C0
P2860
TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
TRIO amplification and abundan ...... tion in urinary bladder cancer
@ast
TRIO amplification and abundan ...... tion in urinary bladder cancer
@en
TRIO amplification and abundan ...... tion in urinary bladder cancer
@nl
type
label
TRIO amplification and abundan ...... tion in urinary bladder cancer
@ast
TRIO amplification and abundan ...... tion in urinary bladder cancer
@en
TRIO amplification and abundan ...... tion in urinary bladder cancer
@nl
prefLabel
TRIO amplification and abundan ...... tion in urinary bladder cancer
@ast
TRIO amplification and abundan ...... tion in urinary bladder cancer
@en
TRIO amplification and abundan ...... tion in urinary bladder cancer
@nl
P2093
P2860
P1476
TRIO amplification and abundan ...... tion in urinary bladder cancer
@en
P2093
Guido Sauter
Martina Mirlacher
Michael J Mihatsch
Peter Schraml
Pierre Andre Diener
Robert Maurer
Ronald Simon
Thomas Forster
P2860
P356
10.1016/S0002-9440(10)63275-0
P407
P577
2004-07-01T00:00:00Z